4/2
09:01 am
anvs
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Medium
Report
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
4/2
07:39 am
anvs
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
High
Report
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
4/2
07:30 am
anvs
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
High
Report
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
4/1
08:19 am
anvs
Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in Humans [Yahoo! Finance]
Low
Report
Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in Humans [Yahoo! Finance]
4/1
08:00 am
anvs
Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
Low
Report
Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
3/21
11:34 am
anvs
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet [Yahoo! Finance]
Low
Report
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet [Yahoo! Finance]
3/21
08:06 am
anvs
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
High
Report
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
3/20
07:30 am
anvs
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
High
Report
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
3/18
10:47 am
anvs
Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock? [Yahoo! Finance]
Low
Report
Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock? [Yahoo! Finance]
2/28
08:17 am
anvs
Annovis Bio, Inc. (NYSE: ANVS) had its "hold" rating re-affirmed by analysts at Brookline Capital Management. They now have a $9.00 price target on the stock.
Medium
Report
Annovis Bio, Inc. (NYSE: ANVS) had its "hold" rating re-affirmed by analysts at Brookline Capital Management. They now have a $9.00 price target on the stock.
2/27
08:04 am
anvs
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024 [Yahoo! Finance]
High
Report
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024 [Yahoo! Finance]
2/27
08:00 am
anvs
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
High
Report
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
2/14
07:37 am
anvs
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer's Disease [Yahoo! Finance]
Medium
Report
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer's Disease [Yahoo! Finance]
2/14
07:30 am
anvs
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease
Medium
Report
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease
2/12
09:24 am
anvs
Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects [Seeking Alpha]
Neutral
Report
Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects [Seeking Alpha]
1/30
08:10 am
anvs
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company's Portfolio [Yahoo! Finance]
Medium
Report
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company's Portfolio [Yahoo! Finance]
1/30
08:00 am
anvs
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s Portfolio
Medium
Report
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s Portfolio